Can phage therapy answer the booming antibiotic resistance problem?
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective…
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective…
As we prepare to enter a new decade, we look back on the major milestones…
Taking advantage of the ability of viruses to manipulate life is opening new doors for…
Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from…
The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day…
The Israeli biotech BiomX has raised €28M ($32M) to advance its treatments for acne and…
Immunocore and the US biotech giant Genentech are building on their existing partnership to boost…
With the rise of antimicrobial resistance across the globe, and with a dire lack of…
The human microbiome is emerging as a target for treating a wide range of diseases,…
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with…
One of the last remaining bastions for organic chemists in pharmaceuticals is in antibiotic development.…
Amgen is now months away from a European approval with Imlygic (also known as T-VEC) - the…